Categories LATEST

Take-Two Interactive Software Q2 2024 Earnings: Stay tuned for the live earnings call and real-time transcript

Gaming company Take-Two Interactive Software, Inc. (NASDAQ: TTWO) is set to report its earnings results for the second quarter of 2024 today after markets close.

Listen to Take-Two’s earnings call live and check the real-time transcript

Take-Two has guided for net revenues of $1.26-1.31 billion, net bookings of $1.40-1.45 billion and a net loss of $0.90-1.00 for the second quarter of 2024. Analysts are projecting revenue of $1.41 billion and earnings of $1.04 per share for Q2 2024. This compares to net revenue of $1.39 billion, net bookings of $1.5 billion, and a net loss of $1.54 per share reported in Q2 2023.

In the first quarter of 2024, net revenues increased 17% year-over-year to $1.28 billion and net bookings grew 20% to $1.20 billion. The company reported a net loss of $1.22 per share in Q1 2024.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Infographic: How UnitedHealth Group (UNH) performed in Q1 2025

UnitedHealth Group (NYSE: UNH) reported its first quarter 2025 earnings results today. Total revenues were $109.6 billion compared to $99.8 billion in the same quarter a year ago. Net earnings

INFY Earnings: Infosys Q4 profit drops despite an increase in revenues

Infosys (NYSE: INFY) Thursday reported an increase in revenues for the fourth quarter of 2025. However, Q4 profit declined year-over-year. The software firm’s revenues increased 3.6% year-over-year to $4.73 billion

AXP Earnings: Key quarterly highlights from American Express’ Q1 2025 financial results

American Express Company (NYSE: AXP) reported its first quarter 2025 earnings results today. Consolidated total revenues net of interest expense were $17 billion, up 7% year-over-year. Revenues grew 8% on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close